| |
To characterise descriptively# the relationship between airway inflammation, asthma symptoms, lung function and reliever use, in the two treatment arms measured daily over 24 weeks of treatment
|
Individual patient profiles of daily variations over time in FENO (morning), asthma symptom scores (morning and evening), PEF and FEV1 (morning and evening), and reliever use
|
| |
|
Individual patient profiles of daily variations over time in FENO (morning), asthma symptom scores (morning and evening), PEF and FEV1 (morning and evening), and reliever use between 14 days prior and 28 days after an event. Events include severe exacerbation¶, CompEx (full criteria) [26], single day (in 24 h) with six or more occasions of reliever medication use and FENO >50 ppb
|
| |
|
|
|
|